Trial to Assess Parkinson's Disease (PD) Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to show Rotigotine dose response at four doses of Rotigotine
used with L-dopa in treating advanced stage Parkinson's disease.